Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Mantle Cell Lymphoma

Breast Cancer

Gastrointestinal Cancer

Mantle Cell Lymphoma

CAR T-Cell Therapy Starts to Enter MCL Space

Frederick L. Locke, MD, discusses the ongoing ZUMA-2 trial investigating axi-cel for patients with mantle cell lymphoma.
Read More >>

Taking the Next Step in MCL: Novel Combos and Immunotherapy Under Study

Venetoclax/Ibrutinib Combo Impresses in MCL

MCL Leader Discusses Optimal Disease Management

Goy Lends Insight on Acalabrutinib and Ibrutinib in MCL

Flinn Sheds Light on Advances in MCL and Other Lymphomas

View More Stories >>

View Conference Coverage

2018 AACR Annual Meeting

2018 European Lung Cancer Congress

2018 SGO Annual Meeting

2018 State of the Science Summit on Gastrointestinal Malignancies

2018 State of the Science Summit on Prostate Cancer

CDK 4/6 Inhibitors in Mantle Cell Lymphoma

Dr. Goy Compares Acalabrutinib With Ibrutinib in MCL

Dr. Goy on the Importance of MRD Status in Patients With MCL

Dr. Goy Discusses Ibrutinib With Venetoclax in MCL

OncLive houses thousands of videos that provide updates and information.
See more Videos

Highlights from ASH 2017: Mantle Cell Lymphoma

Investigational Treatment in Mantle Cell Lymphoma

Future Therapy: Bruton's TKI Containing Combinations in MCL

Allogeneic Transplantation in Mantle Cell Lymphoma

Acalabrutinib in Relapsed Mantle Cell Lymphoma

Ibrutinib in Relapsed Mantle Cell Lymphoma

Understanding Relapse in Mantle Cell Lymphoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

How to Properly Utilize MRD Testing

Emerging Agents for Mantle Cell Lymphoma

Acalabrutinib for Treating Mantle Cell Lymphoma

Ongoing Challenges in Treating Mantle Cell Lymphoma

$Treating Relapsed/Refractory Mantle Cell Lymphoma$

Role of Maintenance Therapy in Mantle Cell Lymphoma

Response Assessment in Mantle Cell Lymphoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Ibrutinib in Relapsed Mantle Cell Lymphoma

Drs Danilov, Goy, Leonard, Pagel, and Schuster, discuss ibrutinib (Imbruvica) as a treatment in relapsed mantle cell lymphoma. View Now

Treatments for Relapsed Mantle Cell Lymphoma

Brad S. Kahl, MD, and Richard R. Furman, MD, explain available treatment options for relapsed mantle cell lymphoma. View Now

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approvals in RCC and Chronic ITP, 2018 ELCC Highlights, and More